Controlled release dosage form
US10213403B2 · kind B2 · utility
0Cited by
23References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 13, 2018 |
| Grant date | Feb 26, 2019 |
| Priority date | — |
| Expiry date | Mar 13, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABAB receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABAB receptor agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.